Cidara drops 5% despite 'positive' Phase 3 rezafungin data in candidemia/invasive candidiasis
December 14 2021 - 8:05AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Cidara Therapeutics (NASDAQ:CDTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cidara Therapeutics (NASDAQ:CDTX)
Historical Stock Chart
From Apr 2023 to Apr 2024